+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Poc Hba1C Testing Market Report 2026 - Product Thumbnail Image

Poc Hba1C Testing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hemophilia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hemophilia Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Human Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Insulin - Global Strategic Business Report

  • Report
  • April 2026
  • 376 Pages
  • Global
From
From
From
Insulin Sensitizers Market - Global Strategic Business Report - Product Thumbnail Image

Insulin Sensitizers Market - Global Strategic Business Report

  • Report
  • April 2026
  • 340 Pages
  • Global
From
From
From
Endocrinology Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Endocrinology Drugs Market - Global Strategic Business Report

  • Report
  • April 2026
  • 288 Pages
  • Global
From
From
From
From
Injection Pen Market 2025-2029 - Product Thumbnail Image

Injection Pen Market 2025-2029

  • Report
  • August 2025
  • 223 Pages
  • Global
From
Loading Indicator